CathWorks has completed the enrolment for a randomised controlled trial (RCT), evaluating the FFRangio system in diagnosing and treating coronary artery disease (CAD). The Advancing Cath Lab ...

High genetically predicted LDL was inversely associated with risk for incident diabetes, whereas the opposite trend was ...

the randomized trials have studied fewer than 200 patients ... that ACAM members typically discourage standard therapies for CAD. Instead, the form places the burden of such therapeutic decisions ...

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March ...

PCSK9 Program: Initial Data for the Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102 Expected in the Second Quarter of 2025: VERVE-102, a novel, investigational base editing medicine targeting ...

AstraZeneca said it has created more than 1,200 jobs and invested more than $1.3-billion CAD in Canada since 2023. The ...